Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09OHP
|
|||
| Former ID |
DNCL002863
|
|||
| Drug Name |
Indeglitazar
|
|||
| Synonyms |
PLX-204
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Type-2 diabetes [ICD-11: 5A11; ICD-9: 250] | Discontinued in Phase 2 | [1] | |
| Company |
Plexxikon
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H19NO6S
|
|||
| Canonical SMILES |
COC1=CC=C(C=C1)S(=O)(=O)N2C=C(C3=C2C=CC(=C3)OC)CCC(=O)O
|
|||
| InChI |
1S/C19H19NO6S/c1-25-14-4-7-16(8-5-14)27(23,24)20-12-13(3-10-19(21)22)17-11-15(26-2)6-9-18(17)20/h4-9,11-12H,3,10H2,1-2H3,(H,21,22)
|
|||
| InChIKey |
YMPALHOKRBVHOJ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 835619-41-5
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800022483) | |||
| REF 2 | Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent. Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):262-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.